|
|
Article: GlaxoSmithKline and the Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program.
- Article from:
- Virus Weekly
- Article date:
- December 23, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In a meeting today with former U.S. President and founder of The Carter Center, Jimmy Carter, as well as global health thought leaders from around the world, GlaxoSmithKline (LSE/NYSE: GSK) announced that it has made a $250,000 donation to The Carter Center to assist the Ministry of Health of Ethiopia with launching a program to eliminate lymphatic filariasis (LF). The program will be launched in the Gambella region of Ethiopia, currently known as the most LF-endemic part of the country. The donation to The Carter Center will help enable a two-year initiative to scale up mass drug administration for LF there (see also Public Health).
The announcement was made ...
Related newspaper, magazine, and journal articles:
|